SCHEMBL7950898

SCHEMBL7950898

Cc1ccc2c(c1)NC(=O)C(NC(=O)OC(C)(C)C)CN2C(=O)c1ccco1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
BRD4 O60885 5/20 0.37
ATM Q13315 1/20 0.37
GAA P10253 1/20 0.37
EPHX2 P34913 1/20 0.36
MAPT P10636 2/20 0.35
GLA P06280 1/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176414 0.85 EPHX2 (0.41) HTTSMN1; SMN2ALDH1A1GAAEPHX2
SCHEMBL7950687 0.84 GAA (0.40) ALDH1A1GAAEPHX2MAPTKDM4E
SCHEMBL6176303 0.83 GAA (0.40) ALDH1A1GAAEPHX2MAPTKDM4E
SCHEMBL7959374 0.82 ALDH1A1 (0.43) HTTSMN1; SMN2ALDH1A1GAAEPHX2
SCHEMBL7959365 0.82 NPC1 (0.43) SMN1; SMN2NPC1RAB9AGAAEPHX2
SCHEMBL7950474 0.82 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1GAAEPHX2
SCHEMBL6179125 0.81 EPHX2 (0.39) ALDH1A1BRD4GAAEPHX2MAPT
SCHEMBL7950643 0.81 GAA (0.38) ALDH1A1GAAEPHX2MAPTKDM4E
SCHEMBL6177881 0.81 GAA (0.38) ALDH1A1BRD4GAAEPHX2MAPT
SCHEMBL7950813 0.80 GAA (0.37) ALDH1A1GAAEPHX2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed